Recon: Weight-loss drugs take centerstage at ADA; GSK settles first US Zantac cancer suit ahead of trial

Recon

ReconMichael Mezher

Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy